TAK-329
TAK-329_102
Phase 1 small_molecule completed
Quick answer
TAK-329 for Type 1 Diabetes Mellitus is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Type 1 Diabetes Mellitus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed